0 évaluation0% ont trouvé ce document utile (0 vote)
241 vues2 pages
Jeri logemann: many clinical investigators and clinicians questioned the efficacy of VitalStim in the treatment of oropharyngeal dysphagia. She says VitalStim gave some clinicians an 'easy out' from understanding each patientOs underlying swallow physiology. Logemann says there was an unwillingness initially by the NIH to fund studies of Laetrile to define its true efficacy.
Jeri logemann: many clinical investigators and clinicians questioned the efficacy of VitalStim in the treatment of oropharyngeal dysphagia. She says VitalStim gave some clinicians an 'easy out' from understanding each patientOs underlying swallow physiology. Logemann says there was an unwillingness initially by the NIH to fund studies of Laetrile to define its true efficacy.
Jeri logemann: many clinical investigators and clinicians questioned the efficacy of VitalStim in the treatment of oropharyngeal dysphagia. She says VitalStim gave some clinicians an 'easy out' from understanding each patientOs underlying swallow physiology. Logemann says there was an unwillingness initially by the NIH to fund studies of Laetrile to define its true efficacy.
The Eects of VitalStim on Clinical and Research Thinking
in Dysphagia Jeri A. Logemann, PhD, CCC-SLP, BRS-S 1,2 1 The Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois; and 2 Departments of Head and Neck Surgery Otolaryngology and Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois When VitalStim was rst reported [1] and the man- ufacturer began selling products, many clinical investigators and clinicians began to question the true ecacy of the procedure in the treatment of oro- pharyngeal dysphagia. The data presented in the initial publication [1] were unconvincing because of the poor description of the procedure itself, the mixed use of standard therapy with the VitalStim procedure, and the use of cricopharyngeal myotomy or cri- copharyngeal dilatation in many patients without any clear description of how, why, and when they were performed. In addition, the underlying neurophysio- logic basis for using the procedure that involves surface electrode placement on the external lateral neck was poorly dened. The second reaction to VitalStim was from clinicians eager to oer a uniform treatment proce- dure to their oropharyngeal dysphagic patients without the need for careful assessment of the pa- tients swallow physiology to dene the specic swallow problems from which the patient was suf- fering. VitalStim gave some clinicians an easy out from understanding each patients underlying swal- low physiology, if they so desired. Unfortunately, this led to a large market for VitalStim among clinicians and desperate patients willing to try anything whether or not it had a rm scientic base and known ecacy. This response was similar to the rush in the 1970s to use Laetrile by cancer patients, who went to Mexico to get the magic cure. Interestingly, there was an unwillingness initially by the National Insti- tutes of Health (NIH) to fund studies of Laetrile to dene its true ecacy. In the end, Congress needed to instruct NIH-National Cancer Institute (NCI) to conduct such studies to protect patients. Those studies found that the use of Laetrile had no clinical ecacy [2]. To date, there are very few studies of surface electrical stimulation to the neck for swallowing that support the ecacy of VitalStim. In fact, there are now several studies indicating that the procedure is not eective. This includes the study featured in an article in this issue of Dysphagia that was conducted by a group of clinicians and was designed to eval- uate the actual eectiveness of VitalStim. The fact that the procedure has sparked a great deal of clinical interest and, more importantly, research interest by clinical investigators to systematically evaluate the eectiveness of the procedure is a po- sitive outcome of the attention the procedure has received. Over the years many clinicians have ex- pressed interest in conducting research in various aspects of dysphagia treatment. Often the diculty of conducting research has discouraged these novice clinical investigators and caused them to abandon their research interests. However, the article in this issue of Dysphagia shows clinicians who succeed in pursuing their research until they are able to collect meaningful data for all of us. They are to be con- gratulated. This article presents some interesting, negative data about VitalStim. Correspondence to: J.A. Logemann, PhD, Northwestern Univer- sity, Communication Sciences and Disorders, 2240 Campus Drive, Evanston, IL 60208, USA; E-mail: j-logemann@northwestern.edu Dysphagia 22:1112 (2007) DOI: 10.1007/s00455-006-9039-2 A second study published in this issue of Dysphagia and that was presented at the Medical University of South Carolina - Charleston Swallow- ing Conference (2005) [3] examined the eect of electrical stimulation on the external lateral neck relative to hyolaryngeal elevation during swallow. Results found that electrical stimulation on the neck surface in fact caused downward movement of the hyoid during swallow, probably the result of stimu- lating the sternohyoid muscle rather than the thyro- hyoid muscle, which was the goal of the procedure. Here we nd a physiologic study that increases our understanding of the eects of VitalStim on oro- pharyngeal swallow. One positive eect of VitalStim is that it stimulated our thinking with respect to clinical e- cacy studies. Are negative studies of ecacy truly helpful? I believe they are, if adequate numbers of subjects are included, because they provide us with important information that indicates that the proce- dure under study, in this case VitalStim, has a nega- tive eect on oropharyngeal swallow. Just as the study of Laetrile in cancer patients proved it did not really cure cancer, so do negative studies of VitalStim assist patients and clinicians in determining that the use of VitalStim may not be an ecacious treatment for oropharyngeal dysphagia. The manner in which VitalStim was conceived by its producers and evaluated in publication also has made many clinical investigators and clinicians think carefully about how a new procedure should be de- signed, evaluated, and introduced for commercial gain. Generally, there should be a strong neuro- physiologic rationale for the procedures application to a particular patient group or groups, followed by studies that dene the ecacy of the procedure in a small group of patients, preferably a homogeneous group, then study of a larger group of patients, preferably several groups representing dierent diagnoses; and then a clinical trial should be devel- oped if the procedure is found to have strong ecacy in smaller-group studies. None of these steps had been done by the producers of VitalStim. In summary, VitalStim has provided us with helpful food for thought about the methods used for introducing new therapy procedures. The pro- ducers of VitalStim have not faced their responsibility to the clinical research world and patients with dys- phagia who are desperate for additional treatment procedures. Clearly, much more research is needed to determine whether VitalStim or other methods of neuromuscular electrical stimulation have any role to play in the management of oropharyngeal swallowing diculties in any specic patient group. In the meantime, the best advice is Clinician and patient, beware. References 1. Freed ML, Freed L, Chatburn RL, Christian M: Electrical stimulation for swallowing disorders caused by stroke. Respiratory Care 46(5):466471, 2001 2. Milazzo S, Ernst E, Lejeune S, Schmidt, K: Cochrane Data- base Syst Rev 2006 Apr 19;(2):CD005476 [review] 3. Ludlow C: Physiological eects of surface electrical stimula- tion vs. intramuscular stimulation on swallowing in chronic pharyngeal dysphagia. Presented at the Charleston Swallow- ing Conference, Charleston, SC, October 6, 2005 12 J.A. Logemann: Eects of VitalStim in Dysphagia